144 related articles for article (PubMed ID: 2576472)
1. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
[TBL] [Abstract][Full Text] [Related]
2. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
6. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
[TBL] [Abstract][Full Text] [Related]
7. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
8. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
[TBL] [Abstract][Full Text] [Related]
11. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
12. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
[TBL] [Abstract][Full Text] [Related]
14. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
Roberts RA; Soames AR; Gill JH; James NH; Wheeldon EB
Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391
[TBL] [Abstract][Full Text] [Related]
15. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver.
Stäubli W; Bentley P; Bieri F; Fröhlich E; Waechter F
Carcinogenesis; 1984 Jan; 5(1):41-6. PubMed ID: 6140087
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
Préat V; de Gerlache J; Lans M; Taper H; Roberfroid M
Carcinogenesis; 1986 Jun; 7(6):1025-8. PubMed ID: 2871946
[TBL] [Abstract][Full Text] [Related]
19. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms.
Ward JM
J Natl Cancer Inst; 1983 Oct; 71(4):815-23. PubMed ID: 6194333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
